Response to McMullan et al, "Safety of dermatologic medications in pregnancy and lactation: An Update - Part I: Pregnancy," and Yaghi et al., "Safety of dermatologic medications in pregnancy and lactation: An Update - Part II: Lactation".

Smith, Nicole A; Shaw, Katharina S

Response to McMullan et al, "Safety of dermatologic medications in pregnancy and lactation: An Update - Part I: Pregnancy," and Yaghi et al., "Safety of dermatologic medications in pregnancy and lactation: An Update - Part II: Lactation".

Smith, Nicole A; Shaw, Katharina S.

Afiliação

Smith NA; Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Shaw KS; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: katharina.shaw@pennmedicine.upenn.edu.

J Am Acad Dermatol ; 91(2): e33-e34, 2024 Aug.

Article em En | MEDLINE | ID: mdl-38614251

Assuntos

Fármacos Dermatológicos; Lactação; Humanos; Feminino; Gravidez; Lactação/efeitos dos fármacos; Fármacos Dermatológicos/efeitos adversos; Fármacos Dermatológicos/uso terapêutico; Complicações na Gravidez/tratamento farmacológico; Aleitamento Materno

Palavras-chave

lactation; maternal-fetal medicine; multidisciplinary care; pregnancy; rituximab; safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lactação / Fármacos Dermatológicos Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google